Skip to main content
Clinical Trials/JPRN-UMIN000053314
JPRN-UMIN000053314
Completed
未知

Serum trypsin as an early predictor of post-endoscopic retrograde pancreatography pancreatitis - Serum trypsin as an early predictor of post-endoscopic retrograde pancreatography pancreatitis

Wakayama Medical University0 sites147 target enrollmentJanuary 10, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
patients who wil be plaining to undergo ERCP
Sponsor
Wakayama Medical University
Enrollment
147
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 10, 2024
End Date
October 19, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • they had acute pancreatitis, defined as two of the following three features: (1\) abdominal pain consistent with acute pancreatitis (acute onset of persistent, severe, epigastric pain often radiating to the back); (2\) pancreatic enzyme activity at least the upper limit of normal; and (3\) characteristic findings of acute pancreatitis on computed tomography(CT), magnetic resonance imaging or transabdominal ultrasound

Outcomes

Primary Outcomes

Not specified

Similar Trials